Shares of Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $638.58.
A number of brokerages have recently commented on SNPS. Robert W. Baird cut their price objective on Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Needham & Company LLC reiterated a “buy” rating and set a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Rosenblatt Securities reiterated a “buy” rating and set a $660.00 price objective on shares of Synopsys in a research report on Tuesday, February 25th. Morgan Stanley cut their target price on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research note on Monday, February 24th. Finally, Wells Fargo & Company cut their target price on shares of Synopsys from $540.00 to $520.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 27th.
Check Out Our Latest Stock Analysis on SNPS
Synopsys Stock Performance
Insider Transactions at Synopsys
In other news, insider Geus Aart De sold 15,705 shares of the company’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the transaction, the insider now directly owns 116,671 shares of the company’s stock, valued at approximately $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is owned by insiders.
Institutional Investors Weigh In On Synopsys
Large investors have recently bought and sold shares of the business. Kieckhefer Group LLC bought a new stake in Synopsys in the fourth quarter worth $27,000. Ameriflex Group Inc. bought a new stake in Synopsys in the fourth quarter worth $29,000. Whipplewood Advisors LLC bought a new stake in Synopsys in the fourth quarter worth $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in Synopsys in the fourth quarter worth $34,000. Finally, Sierra Ocean LLC bought a new stake in Synopsys in the fourth quarter worth $39,000. 85.47% of the stock is currently owned by institutional investors.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- What is the S&P/TSX Index?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How to Invest in Biotech Stocks
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Why Are Stock Sectors Important to Successful Investing?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.